REGULUS THERAPEUTICS INC (RGLS) Stock Cash Flow
NASDAQ:RGLS - Nasdaq - US75915K3095 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -46.36M | -30.04M | -28.32M | -27.81M | -15.73M | |||
| Depreciation Amortization | 347.00K | 227.00K | 122.00K | 459.00K | 467.00K | |||
| Change In Working Capital | -1.88M | 257.00K | 550.00K | 914.00K | -41.00K | |||
| Interest Paid | 66.00K | 447.00K | 491.00K | 729.00K | 1.36M | |||
| Taxes Paid | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K | |||
| Other non cash items | 6.22M | 2.79M | 2.13M | 2.31M | 2.77M | |||
| OPERATING CASH FLOW | -41.67M | -26.77M | -25.53M | -24.13M | -12.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -340.00K | -613.00K | -361.00K | -251.00K | 0.00 | |||
| Other Investing Activity | -35.64M | 15.10M | -14.76M | 0.00 | -11.00K | |||
| INVESTING CASH FLOW | -35.98M | 14.49M | -15.12M | -251.00K | -11.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.38M | -3.30M | 0.00 | -80.00K | -9.62M | |||
| Stock Issued/Repurchased | 93.79M | 15.12M | 4.49M | 21.46M | 962.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | 32.36M | 18.17M | |||
| FINANCING CASH FLOW | 92.42M | 11.82M | 4.49M | 53.74M | 9.51M | |||
| CHANGE IN CASH | 14.76M | -461.00K | -36.16M | 29.36M | -3.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -41.67M | -26.77M | -25.53M | -24.13M | -12.54M | |||
| Capital Expenditure | -340.00K | -613.00K | -361.00K | -251.00K | 0.00 | |||
| FREE CASH FLOW | -42.01M | -27.38M | -25.89M | -24.38M | -12.54M | |||
All data in USD